Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02719691
Title Phase I Study of MLN0128 and MLN8237 in Patients With Advanced Solid Tumors and Metastatic Triple-negative Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

triple-receptor negative breast cancer

Advanced Solid Tumor

Therapies

Alisertib + Sapanisertib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.